Skip to content

Saudi cohort v1 · GRCh38 · 1,378 participants

Enigma Clinical Platform

Genomic evidence for variant interpretation and discovery.

Enigma Genomics

1,378
exomes and genomes
10M+
high-confidence variants
58.9K+
Saudi-enriched variants
GRCh38
reference build

Search examples

54 examples, one for each format the search box accepts. Select one to run it; coordinates are GRCh38 unless prefixed with hg19.

Genes and transcripts

Variant identifiers

HGVS

Regions

Structural variants and CNVs

Cytogenetics

Fusions and repeat expansions

Pharmacogenomics, phenotypes and diseases

Every format with notes and variations

What you can explore

Navigate across genes, fusions, variants, copy number alterations, repeat expansions, and clinical star evidence tiers.

SNVs & indelsStructural variants & CNVsRepeat expansionsGene fusionsChromosomal changes & UPDPharmacogenomics

Explore each variant class below. Clinical significance is labelled separately.

Genomic Architecture & Evidence Standards

Enigma Clinical connects population variation with clinical evidence and pharmacogenomics for research.

Variant classes and genomic context

Enigma Clinical integrates multiple genomic classes into a single reference catalogue, standardized on GRCh38:

  • SNV & InDel
    Single Nucleotide Variants & Small Indels

    Over 713,000 quality-filtered sites annotated with functional consequences (VEP), CADD, REVEL, and SpliceAI scores.

  • CNV & SV
    Copy Number & Structural Variants

    Deletions, duplications, chromosomal rearrangements, cytobands, and mobile-element insertions with exact breakpoint coordinates.

  • RE / STR
    Short Tandem Repeat Expansions

    Pathogenic repeat loci for neurodegenerative and muscular disorders, including Huntington (HTT), Fragile X (FMR1), and ALS (C9ORF72).

  • Fusion
    Gene Fusions & Translocations

    Oncogenic breakpoint fusions (e.g., BCR::ABL1, EML4::ALK) indexed by 5′ and 3′ partner genes and chromosome junctions.

Clinical Evidence Stars & Pharmacogenomics ⭐

Standardized interpretation frameworks ensure variant findings are ready for clinical contextualization:

  • ★★★★
    ClinVar 0–4 Star Review System

    Variants categorized by curation rigor: Practice Guidelines (★★★★), Expert Panels (★★★), Multiple Submitters (★★), and Single Submitters (★).

  • CPIC / PGx
    Pharmacogenomics Star Alleles

    Standardized star-allele nomenclature (e.g. CYP2C19*2, CYP2D6*4, SLCO1B1*5, HLA-B*57:01) to support precision medicine and dosage optimization.

  • Saudi Baseline
    Population-Specific Novelty

    Over 58,900 variants observed in Saudi individuals are unrepresented in global reference datasets, providing an essential local baseline.

The data

Saudi cohort

Release
Saudi cohort v1
Samples
1,378
Sequencing
Whole-exome sequencing
Participants
Healthy individuals and patients with childhood-onset genetic disorders
Reference build
GRCh38
Quality control
Genotypes with GQ < 20 removed; low-quality sites flagged
How the data were processed

Reference data sources

Work with the data

Request data access

Access is limited to approved institutions and researchers in accordance with ethical guidelines and data-sharing policies. Write to the data access team to apply.

sgp-data@enigmagenomics.com

Contribute data

Laboratories and research centres interested in contributing genomic data can submit a request after signing in.

Start a submission request

Partnerships

For institutional collaborations and formal partnerships with the Enigma Clinical team.

sgp-partnerships@enigmagenomics.com

Enigma Clinical Platform is built and operated by Enigma Genomics, connecting population data and public genomic evidence for research and variant interpretation.